Total Payments
$1,955
2023 Payments
$130.60
Companies
13
Transactions
128
Medicare Patients
754
Medicare Billing
$86,791
Payment Breakdown by Category
Food & Beverage$1,832 (93.7%)
Education$122.98 (6.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,832 | 124 | 93.7% |
| Education | $122.98 | 4 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $403.74 | 27 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $267.00 | 17 | $0 (2019) |
| Allergan, Inc. | $257.04 | 16 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $227.05 | 16 | $0 (2020) |
| Alkermes, Inc. | $198.88 | 11 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $156.30 | 11 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $131.67 | 10 | $0 (2019) |
| Shire North American Group Inc | $84.86 | 4 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.83 | 4 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $47.54 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $130.60 | 10 | ABBVIE INC. ($130.60) |
| 2022 | $126.55 | 8 | ABBVIE INC. ($126.55) |
| 2021 | $146.59 | 9 | AbbVie Inc. ($146.59) |
| 2020 | $58.87 | 4 | Allergan, Inc. ($40.28) |
| 2019 | $369.71 | 25 | Alkermes, Inc. ($92.34) |
| 2018 | $575.26 | 37 | Allergan Inc. ($184.18) |
| 2017 | $547.84 | 35 | Otsuka America Pharmaceutical, Inc. ($162.72) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 114 | 166 | $37,054 | $10,670 |
| 2022 | 6 | 219 | 364 | $79,144 | $25,274 |
| 2021 | 6 | 216 | 406 | $88,737 | $29,170 |
| 2020 | 7 | 205 | 365 | $67,546 | $21,677 |
Total Patients
754
Total Services
1,301
Medicare Billing
$86,791
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 87 | $23,403 | $7,252 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 58 | $11,136 | $2,671 | 24.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 21 | $2,515 | $746.51 | 29.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 108 | $17,820 | $6,003 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 108 | $20,736 | $5,747 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 49 | $13,181 | $4,010 | 30.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 25 | 27 | $10,071 | $3,776 | 37.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 35 | 43 | $10,492 | $3,494 | 33.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 29 | $6,844 | $2,244 | 32.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 38 | 148 | $24,420 | $8,258 | 33.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 32 | 41 | $15,033 | $5,500 | 36.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 60 | $15,932 | $5,140 | 32.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 84 | $15,804 | $4,376 | 27.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 29 | 40 | $9,760 | $3,273 | 33.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 33 | $7,788 | $2,622 | 33.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 25 | 127 | $20,955 | $7,268 | 34.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 44 | 73 | $12,994 | $3,644 | 28.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 49 | 66 | $7,656 | $2,379 | 31.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 17 | 17 | $5,457 | $1,915 | 35.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 23 | $5,428 | $1,897 | 34.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 26 | $6,318 | $1,860 | 29.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 18 | 19 | $4,636 | $1,594 | 34.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 14 | 14 | $4,102 | $1,120 | 27.3% |
About Dr. Paul Papadimitriou, MD
Dr. Paul Papadimitriou, MD is a Psychiatry healthcare provider based in Wheeling, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801909510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Papadimitriou, MD has received a total of $1,955 in payments from pharmaceutical and medical device companies, with $130.60 received in 2023. These payments were reported across 128 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,832).
As a Medicare-enrolled provider, Papadimitriou has provided services to 754 Medicare beneficiaries, totaling 1,301 services with total Medicare billing of $86,791. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Wheeling, WV
- Active Since 08/16/2006
- Last Updated 04/06/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1801909510
Products in Payments
- VRAYLAR (Drug) $650.18
- LATUDA (Drug) $227.05
- ABILIFY MAINTENA (Drug) $167.80
- Fanapt (Drug) $156.30
- REXULTI (Drug) $141.55
- Trintellix (Drug) $103.65
- ARISTADA (Drug) $92.34
- Aristada 441 mg (Drug) $84.03
- INVEGA SUSTENNA (Drug) $81.63
- VYVANSE (Drug) $64.39
- SPRAVATO (Drug) $50.04
- AUSTEDO (Drug) $47.54
- Dyanavel XR (Drug) $24.23
- Vivitrol 380 mg (Drug) $22.51
- MYDAYIS (Drug) $20.47
- Quillivant XR (Drug) $11.11
- VIIBRYD (Drug) $10.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Wheeling
Dr. Ryan Wakim, M.d, M.D
Psychiatry — Payments: $502,515
Psychiatry $502,515
Steven Corder, Md, MD
Psychiatry — Payments: $74,356
Psychiatry $74,356
Dr. Alfredo Aguirre, M.d, M.D
Psychiatry — Payments: $2,104
Psychiatry $2,104
Sorin Nica, Md, MD
Psychiatry — Payments: $303.69
Psychiatry $303.69
Maria Moreno, Md, MD
Psychiatry — Payments: $289.35
Psychiatry $289.35